Literature DB >> 28643625

Microbial Interactions and Interventions in Colorectal Cancer.

Terence Van Raay1, Emma Allen-Vercoe1.   

Abstract

Recently, several lines of evidence that indicate a strong link between the development of colorectal cancer (CRC) and aspects of the gut microbiota have become apparent. However, it remains unclear how changes in the gut microbiota might influence carcinogenesis or how regional organization of the gut might influence the microbiota. In this review, we discuss several leading theories that connect gut microbial dysbiosis with CRC and set this against a backdrop of what is known about proximal-distal gut physiology and the pathways of CRC development and progression. Finally, we discuss the potential for gut microbial modulation therapies, for example, probiotics, antibiotics, and others, to target and improve gut microbial dysbiosis as a strategy for the prevention or treatment of CRC.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28643625     DOI: 10.1128/microbiolspec.BAD-0004-2016

Source DB:  PubMed          Journal:  Microbiol Spectr        ISSN: 2165-0497


  18 in total

1.  The exosome secretion inhibitor neticonazole suppresses intestinal dysbacteriosis-induced tumorigenesis of colorectal cancer.

Authors:  Lei Gu; Yidong Xu; Wangyan Xu; Meng Li; Hui Su; Cong Li; Zhongchen Liu
Journal:  Invest New Drugs       Date:  2019-03-19       Impact factor: 3.850

2.  Differential expression of tumor-associated genes and altered gut microbiome with decreased Akkermansia muciniphila confer a tumor-preventive microenvironment in intestinal epithelial Pten-deficient mice.

Authors:  Cody Howe; Su Jin Kim; Jonathon Mitchell; Eunok Im; Yong Sung Kim; You Sun Kim; Sang Hoon Rhee
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-10-04       Impact factor: 5.187

Review 3.  Precision Nutrition for Targeting Lipid Metabolism in Colorectal Cancer.

Authors:  Cristina Aguirre-Portolés; Lara P Fernández; Ana Ramírez de Molina
Journal:  Nutrients       Date:  2017-09-28       Impact factor: 5.717

Review 4.  Oral hygiene might prevent cancer.

Authors:  Oscar J Cordero; Rubén Varela-Calviño
Journal:  Heliyon       Date:  2018-11-02

Review 5.  Novel cancer therapy targeting microbiome.

Authors:  Tatsuya Nagano; Takehiro Otoshi; Daisuke Hazama; Tatsunori Kiriu; Kanoko Umezawa; Naoko Katsurada; Yoshihiro Nishimura
Journal:  Onco Targets Ther       Date:  2019-05-13       Impact factor: 4.147

6.  Metabolic models predict bacterial passengers in colorectal cancer.

Authors:  Annemarie Boleij; Martijn A Huynen; Daniel R Garza; Rahwa Taddese; Jakob Wirbel; Georg Zeller; Bas E Dutilh
Journal:  Cancer Metab       Date:  2020-02-10

Review 7.  Rethinking the bile acid/gut microbiome axis in cancer.

Authors:  John P Phelan; F Jerry Reen; Jose A Caparros-Martin; Rosemary O'Connor; Fergal O'Gara
Journal:  Oncotarget       Date:  2017-12-01

8.  Immunogenicity of a Fap2 peptide mimotope of Fusobacterium nucleatum and its potential use in the diagnosis of colorectal cancer.

Authors:  Leonardo A Guevarra; Andrea Claudine F Afable; Patricia Joyce O Belza; Karen Joy S Dy; Scott Justin Q Lee; Teresa T Sy-Ortin; Pia Marie S P Albano
Journal:  Infect Agent Cancer       Date:  2018-04-02       Impact factor: 2.965

9.  Efficacy of fecal microbiota transplantation in a patient with chronic intractable constipation.

Authors:  Tadashi Ohara; Tatsuo Suzutani
Journal:  Clin Case Rep       Date:  2018-09-09

10.  Intestinal dysbacteriosis activates tumor-associated macrophages to promote epithelial-mesenchymal transition of colorectal cancer.

Authors:  Guangsheng Wan; Manli Xie; Hongjie Yu; Hongyu Chen
Journal:  Innate Immun       Date:  2018-09-23       Impact factor: 2.680

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.